Tenth Annual PTCTC Educational Meeting at ASPHO - In-person
The Pediatric Transplantation and Cellular Therapy Consortium, in collaboration with ASPHO, will present its 10th Annual Full Day Conference. The theme of this conference is Chronic Graft-versus-Host Disease (GVHD) and the Management of its Sequelae. Conference sessions will review donor selection and access to care, the current state of the biology of chronic GVHD, patient care and management of chronic GVHD, and reintegration back to work and school after transplant. Abstract of new research findings will be presented, followed by an exciting evening of mentoring and networking with Meet the Professors!
Tuesday, May 9, 2023
Fort Worth, TX - Fort Worth Convention Center.
6:30am-5:15pm CT - Main meeting - Room 202 ABC
5:15-6:30pm CT - Poster Session - Room 202 D
6:30-8:30pm CT - Evening Event/Mentoring and Networking, "Meet the Professors" - TP Tavern
View Draft agenda here
View the 2023 PTCTC Meeting speaker, planner, and reviewer disclosures here.
Hotel and Travel Information: http://aspho.org/meetings/conference/2023-conference/hotel-and-travel
*Lactation rooms available at the Convention Center. Please see meeting contact onsite.
Any questions, please reach out to PTCTC@nmdp.org
Continuing Medical Education Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Society of Pediatric Hematology/Oncology (ASPHO) and the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC).
The American Society of Pediatric Hematology/Oncology is accredited by the ACCME to provide continuing medical education for physicians.
The American Society of Pediatric Hematology/Oncology designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, ASPHO requires all planners, faculty (presenters and moderators), reviewers, teachers, authors, and any others involved in the development of CME content to disclose all financial relationships they have with ineligible companies in the last 24 months. Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. ASPHO also requires disclosure of the intent to discuss unlabeled or investigational use(s) of a commercial product or investigational use of a product not yet approved for this purpose. The ASPHO Accreditation Subcommittee reviews all financial relationships as submitted in the disclosure form by planners and presenters and mitigates such conflicts to ensure the content of the activity is aligned with the interests of the public.
The material presented in this activity represents the opinion of the speakers and not necessarily the views of ASPHO.